Financial Gravity Asset Management, Inc. Collegium Pharmaceutical, Inc Transaction History

Financial Gravity Asset Management, Inc.

  • $400 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$31.23 - $40.91 $343 - $450
11 New
11 $445,000
Q2 2023

Aug 08, 2023
BUY
$21.06 - $24.0 $442 - $504
21 New
21 $237,000
Q4 2022

Feb 15, 2023
SELL
$16.14 - $23.55 $3,502 - $5,110
-217 Reduced 90.42%
23 $908,000
Q3 2022

Nov 03, 2022
BUY
$15.46 - $20.1 $3,710 - $4,824
240 New
240 $2.07 Million

Others Institutions Holding COLL

# of Institutions
249
Shares Held
36.2M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.11B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Financial Gravity Asset Management, Inc. Portfolio

Follow Financial Gravity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email